The Stroke Center
The Stroke Center Home
About Stroke & the Brain
What Is Stroke?
Types of Stroke
Risk Factors for Stroke
Anatomy of the Brain
Stroke Statistics
About The UH Stroke Center
The Gold Standard
The UH Stroke Center
Meet the Staff
Contact Us
Prevention
Introduction
Managing Lifestyle Risks
Managing Risky Conditions
Drug Treatments
Diagnosis
Introduction
The Role of the Patient
The Role of EMS
In-Hospital Diagnosis
Treatment & Rehabilitation
Introduction
Acute Ischemic Stroke
Acute Hemorrhagic Stroke
Intensive Care
Stroke Rehabilitation
Research & Resources
Clinical Trials in Progress
Research Findings
Internet Resources
Glossary
The Stroke CenterResearch & ResourcesClinical Trials in Progress Printer Friendly Page
Endarterectomy vs. Stenting in Treatment of Carotid Artery Stenosis. The University Hospital Stroke Center is a principal investigational site for a nationwide, multicenter study comparing outcomes achieved through stent-assisted angioplasty with outcomes achieved through endarterectomy. The Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) is looking at the use of these procedures in treating carotid artery stenosis to prevent recurrent strokes in patients who have had a transient ischemic attack (TIA) or mild ischemic stroke.

Warfarin vs. Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial. The University Hospital Stroke Center is a principal investigational site for a nationwide, multicenter study sponsored by the National Institute of Neurological Disorders and Stroke comparing two drugs commonly used in stroke prevention. The study will determine which of two commonly used treatments for ischemic stroke patients — Warfarin, an anticoagulant, or aspirin, a drug that affects platelet function — is better for preventing death and stroke in patients with poor heart function (i.e., patients who have heart failure or a reduced pumping action of the heart muscle).
Printer Friendly Page